In summary, we reveal findings of potential biological and epidemiological importance to the SARS-CoV-2 infection, i.e. the signature of age of ACE2 expression in tissues of relevance to COVID-19 and the lack of association between common cardiovascular and metabolic comorbidities of COVID-19 (i.e. hypertension, diabetes) on the renal expression of the SARS-CoV-2 entry receptor. The gene discussed is ACE2; the disease is COVID-19.